Skip to main content
logo
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.450
-0.030 (-2.03%)
At close: Oct 23, 2025, 4:00 PM EDT
1.460
+0.010 (0.66%)
After-hours: Oct 23, 2025, 7:19 PM EDT

SXTP Revenue

60 Degrees Pharmaceuticals had revenue of $307.87K in the quarter ending June 30, 2025, with 144.93% growth. This brings the company's revenue in the last twelve months to $984.49K, up 128.70% year-over-year. In the year 2024, 60 Degrees Pharmaceuticals had annual revenue of $681.35K with 168.70% growth.

Revenue (ttm)
$984.49K
Revenue Growth
+128.70%
P/S Ratio
1.58
Revenue / Employee
$328,165
Employees
3
Market Cap
5.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024681.35K427.77K168.70%
Dec 31, 2023253.57K-257.64K-50.40%
Dec 31, 2022511.21K-5.84M-91.95%
Dec 31, 20216.35M3.80M149.18%
Dec 31, 20202.55M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

SXTP News

More News